Mirae Asset Securities (Usa) Inc. Viking Therapeutics, Inc. Transaction History
Mirae Asset Securities (Usa) Inc.
- $2.48 Trillion
- Q3 2024
A detailed history of Mirae Asset Securities (Usa) Inc. transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Securities (Usa) Inc. holds 34,036 shares of VKTX stock, worth $1.76 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
34,036Holding current value
$1.76 Million% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding VKTX
# of Institutions
473Shares Held
66.2MCall Options Held
5.72MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$525 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$311 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$241 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$109 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$96.8 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $3.96B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...